VAERS reports by lot

GSK Varicella/Shingles lot 4ZF42: VAERS reports

43 VAERS reports list lot 4ZF42 as a GSK Varicella/Shingles vaccine, received between 2018-11-10 and 2020-03-19. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
43
Reports
2%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)3524%
Injection-site / Local reaction3323%
Dermatological (non-injection-site)2316%
Neurological1510%
Musculoskeletal139%
Allergic / Anaphylactic118%
Gastrointestinal43%
Cardiac / Cardiovascular32%
Respiratory32%
Psychiatric / Neuropsychiatric21%
Thrombotic / Hematological11%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida7
Pennsylvania5
Connecticut3
Maine2
Georgia2
Virginia2
Illinois2
Missouri2
California1
Maryland1
Arizona1
District of Columbia1

Reports by month received

2018-1114
2018-1211
2019-017
2019-022
2019-032
2019-042
2019-054
2020-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.